These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30118825)

  • 1. Cortical thickness in major depressive disorder: A systematic review and meta-analysis.
    Suh JS; Schneider MA; Minuzzi L; MacQueen GM; Strother SC; Kennedy SH; Frey BN
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():287-302. PubMed ID: 30118825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional increases of cortical thickness in untreated, first-episode major depressive disorder.
    Qiu L; Lui S; Kuang W; Huang X; Li J; Li J; Zhang J; Chen H; Sweeney JA; Gong Q
    Transl Psychiatry; 2014 Apr; 4(4):e378. PubMed ID: 24713859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical Thickness in Individuals at High Familial Risk of Mood Disorders as They Develop Major Depressive Disorder.
    Papmeyer M; Giles S; Sussmann JE; Kielty S; Stewart T; Lawrie SM; Whalley HC; McIntosh AM
    Biol Psychiatry; 2015 Jul; 78(1):58-66. PubMed ID: 25534753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
    Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
    EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study.
    Tu PC; Chen LF; Hsieh JC; Bai YM; Li CT; Su TP
    Psychiatry Res; 2012 Jun; 202(3):206-13. PubMed ID: 22521631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report.
    Suh JS; Minuzzi L; Raamana PR; Davis A; Hall GB; Harris J; Hassel S; Zamyadi M; Arnott SR; Alders GL; Sassi RB; Milev R; Lam RW; MacQueen GM; Strother SC; Kennedy SH; Frey BN
    Neuroimage Clin; 2020; 25():102178. PubMed ID: 32036277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prefrontal and parietal cortical thickness does not correlate with anhedonia in patients with untreated first-episode major depressive disorders.
    Yang XH; Wang Y; Huang J; Zhu CY; Liu XQ; Cheung EF; Xie GR; Chan RC
    Psychiatry Res; 2015 Oct; 234(1):144-51. PubMed ID: 26382106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface vulnerability of cerebral cortex to major depressive disorder.
    Peng D; Shi F; Li G; Fralick D; Shen T; Qiu M; Liu J; Jiang K; Shen D; Fang Y
    PLoS One; 2015; 10(3):e0120704. PubMed ID: 25793287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical thickening in remitters compared to non-remitters with major depressive disorder following 8-week antidepressant treatment.
    Saricicek Aydogan A; Oztekin E; Esen ME; Dusmez S; Gelal F; Besiroğlu L; Zorlu N
    Acta Psychiatr Scand; 2019 Sep; 140(3):217-226. PubMed ID: 31250445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder.
    Na KS; Won E; Kang J; Chang HS; Yoon HK; Tae WS; Kim YK; Lee MS; Joe SH; Kim H; Ham BJ
    Sci Rep; 2016 Feb; 6():21089. PubMed ID: 26876488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical abnormalities and association with symptom dimensions across the depressive spectrum.
    Lener MS; Kundu P; Wong E; Dewilde KE; Tang CY; Balchandani P; Murrough JW
    J Affect Disord; 2016 Jan; 190():529-536. PubMed ID: 26571102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant cortical neurodevelopment in major depressive disorder.
    Schmitgen MM; Depping MS; Bach C; Wolf ND; Kubera KM; Vasic N; Hirjak D; Sambataro F; Wolf RC
    J Affect Disord; 2019 Jan; 243():340-347. PubMed ID: 30261449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of cortical thickness abnormalities in medication-free patients with major depressive disorder.
    Li Q; Zhao Y; Chen Z; Long J; Dai J; Huang X; Lui S; Radua J; Vieta E; Kemp GJ; Sweeney JA; Li F; Gong Q
    Neuropsychopharmacology; 2020 Mar; 45(4):703-712. PubMed ID: 31694045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential brain structural alterations in major depressive disorder: A voxel-wise meta-analysis on first episode, medication-naive patients.
    Peng W; Chen Z; Yin L; Jia Z; Gong Q
    J Affect Disord; 2016 Jul; 199():114-23. PubMed ID: 27100056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional decreases of cortical thickness in major depressive disorder and their correlation with illness duration: a case-control study.
    Wang F; Hou X; Guo X; Zang C; Wu G; Zhao J
    Front Psychiatry; 2024; 15():1297204. PubMed ID: 38322142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical thickness, cortical and subcortical volume, and white matter integrity in patients with their first episode of major depression.
    Han KM; Choi S; Jung J; Na KS; Yoon HK; Lee MS; Ham BJ
    J Affect Disord; 2014 Feb; 155():42-8. PubMed ID: 24210630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced cerebral cortex thickness is related to overexpression of exosomal miR-146a-5p in medication-free patients with major depressive disorder.
    Deng Y; Gong P; Han S; Zhang J; Zhang S; Zhang B; Lin Y; Xu K; Wen G; Liu K
    Psychol Med; 2023 Oct; 53(13):6253-6260. PubMed ID: 36426595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness.
    Radoman M; Hoeppner SS; Schuster RM; Evins AE; Gilman JM
    Cogn Affect Behav Neurosci; 2019 Aug; 19(4):1047-1058. PubMed ID: 30809764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural correlates during working memory processing in major depressive disorder.
    Wang XL; Du MY; Chen TL; Chen ZQ; Huang XQ; Luo Y; Zhao YJ; Kumar P; Gong QY
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():101-8. PubMed ID: 25174680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.